Aprea Therapeutics, Inc. (APRE)
0.849
-0.04
(-4.08%)
USD |
NASDAQ |
Mar 03, 16:00
0.8285
-0.02
(-2.41%)
Pre-Market: 08:10
Aprea Therapeutics Research and Development Expense (Annual) : 9.364M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Modular Medical, Inc. | 14.70M |
| Ernexa Therapeutics, Inc. | 4.604M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Tango Therapeutics, Inc. | 143.92M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |